Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29932

Title:	Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies
Authors:	VAN WIJMEERSCH, Bart Buffels, R. Clinch, S. Kuhelj, R. Wei, W. Vermersch, P.
Issue Date:	2019
Publisher:	SAGE PUBLICATIONS LTD
Source:	MULTIPLE SCLEROSIS JOURNAL, 25(S2), p. 824-825
Notes:	[Van Wijmeersch, B.] Univ Hasselt, Overpelt, Belgium. [Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Overpelt, Belgium. [Buffels, R.; Kuhelj, R.; Wei, W.] F Hoffmann La Roche Ltd, Basel, Switzerland. [Clinch, S.] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England. [Vermersch, P.] Univ Lille, Lille, France.
Keywords:	Clinical Neurology; Neurosciences
Document URI:	http://hdl.handle.net/1942/29932
ISSN:	1352-4585
e-ISSN:	1477-0970
ISI #:	000485303103278
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

Check